期刊文献+

增生性玻璃体视网膜病变动物模型的改进和评价 被引量:2

Evaluation and Improvement of Proliferative Vitreoretinopathy Model
下载PDF
导出
摘要 增生性玻璃体视网膜病变是导致视网膜脱离手术失败的主要原因,建立动物模型能更好的研究其发病机理,从而进行防治。本文就PVR动物模型的所用动物、模型的建立方法以及评价和分级进行综述。 Proliferative vitreoretinopathy is the leading cause of failed surgical procedures for the correction of rhegmatogenous retinal detachment.Experimental PVR models help us understand the pathogenesis of the disease and find new therapeutic interventions.We review and summarize the animals used in vivo models of PVR,the methods and the evaluation.
出处 《中国比较医学杂志》 CAS 2011年第1期79-82,共4页 Chinese Journal of Comparative Medicine
基金 国家自然科学基金(30870558) 上海市科技启明星项目(09QA1405100) 2010年上海市科季生物医药处引导项目(10411964900) 2008年上海市卫生局基金项目(2008179)
关键词 增生性玻璃体视网膜病变 模型 动物 评价 Proliferative vitreoretinopathy Model animal Evaluation
  • 相关文献

参考文献22

  • 1Carrington L,McLeod D,Boulton M,et al.IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction[J].Invest Ophthalmol Vis Sci,2000,41:1210-1216. 被引量:1
  • 2Agrawal RN,He SK,Spee C,et al.In vivo models of proliferative vitreoretinopathy[J].Nat Protoc,2007,2(1):67-77. 被引量:1
  • 3Francke M,Faude F,Pannicke T,et al.Electrophysiology of rabbit müller (glial) cells in experimental retinal detachment and PVR[J].Invest Ophthalmol Vis Sci,2001,42:1072-1079. 被引量:1
  • 4万光明.一种新的PVR模型的制作与评价[J].中国实用眼科杂志,2003,21(2):148-149. 被引量:13
  • 5Oshima Y,Sakamoto T,Hisatomi T,et al.Gene transfer of soluble TGF-β type Ⅱ receptor inhibits experimental proliferative vitreoretinopathy[J].Gene Ther,2002,9:1214-1220. 被引量:1
  • 6Bali E,Willermain F,Caspers-Velu L,et al.IL-10 in vivo gene expression in a cell-induced animal model of proliferative vitreoretinopathy[J].Int J Mol Med,2003,12 (3):305-310. 被引量:1
  • 7惠延年,石一宁,张新海,杨琨,宇传华.巨噬细胞诱发的实验性增生性玻璃体视网膜病变中的几种早期炎性细胞因子[J].中华眼科杂志,1999,35(2):140-143. 被引量:13
  • 8Francine FB,Brigitte TG,Thérè se B,et al.EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR[J].Invest Ophthalmol Vis Sci,2000,41:3915 -3924. 被引量:1
  • 9Fasternburg DM,Diddie KR,Sorgente N,et al.A comparison of different cellular innocula in an experimental model of massive periretenal proliferation[J].Am J Ophthalmol,1982,93:559-564. 被引量:1
  • 10Zheng XZ,Li HL,Du LF,et al.A rat model of proliferative vitreoretinopathy induced by RPE-J cells and platelet-rich plasma[J].Asian Biomed,2009,3:1 -9. 被引量:1

二级参考文献13

  • 1金伯泉,细胞和分子免疫学,1995年,129页 被引量:1
  • 2Hui Y N,Graefes Arch Clin Exp Ophthalmol,1993年,231卷,109页 被引量:1
  • 3周廷冲,多肽生长因子.基础与临床,1992年,509页 被引量:1
  • 4Hui Y N,Graefes Arch Clin Exp Ophthalmol,1987年,225卷,279页 被引量:1
  • 5汪谦主编.现代医学实验技术.第一版.北京:人民卫生出版社1997 被引量:1
  • 6Fastenberg DM, Diddie KR, Dorey K, et al. The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am J Ophthalmol 1982 93:565~572 被引量:1
  • 7Freilich DB, Lee PF, Freeman HM. Experimental retinal detachment. Arch Ophthalmol 1966 76:423~436 被引量:1
  • 8De Juan E, Humayun MS, Hatchell DL, et al. Histopathology of experimental periretinal neovascularization. Invest Ophthalmol Vis Sci 1989 30:1495~1503 被引量:1
  • 9Planck SR, Andresevic J, Chen JC, et al. Expression of growth facter mRNA in rabbit PVR model systems. Curr Eye Res 199211:1031~1039 被引量:1
  • 10Pederson JE. Experimental retinal detachment 2. Role of the vitreous. Arch Ophthalmol 1982 100:1156 被引量:1

共引文献35

同被引文献19

  • 1Craiu AM. Proliferative retinopathy, friend or foe [ J ] ? Oftalmo- logia,2009,53 ( 3 ) :64-72. 被引量:1
  • 2Sadaka A, Giuliari GP. Proliferative vitreoretinopathy: current and emerging treatments [ J ]. Clin Ophthalmol, 2012,6 : 1325- 1333. 被引量:1
  • 3Dewey S. Posterior capsular opacification [ J ]. Curr Opin Oph- thalmol,2005,17 ( 1 ) :45-53. 被引量:1
  • 4Cui J, Lei H, Samad A, Basavanthappa S, Maberley D, Matsubara J, et al. PDGF receptors are activated in human epiretinal mem- branes [ J]. Exp Eye Res ,2009,88 ( 3 ) :438-444. 被引量:1
  • 5Lei H, Rheaume MA, Kazlauskas A. Recent developments in our understanding of how platelet derived growth factor ( PDGF ) and its receptors contribute to proliferative vitreoretinopathy -J]. Exp Eye Res,2010,90(3 ) :375-381. 被引量:1
  • 6Moysidis SN, Thanos A, Vawas DG. Mechanisms of inflammation in proliferative vitreoretinopathy: from bench to bedside [ J ]. Mediators Inflamm ,2012,2012:815-937. 被引量:1
  • 7Gama Sosa MA, De Gasperi R, Elder GA. Animal transgenesis: an overview[ J]. Brain Struct Func,2010,214( 2-3 ) :91-109. 被引量:1
  • 8Malecova B, Morris KV. Transcriptional gene silencing through epigenetic changes mediated by non- coding RNAs [ J ]. Curr Opin Mol Ther,2010,12(2) :214-222. 被引量:1
  • 9Gaglione M,Messere A. Recent progress in chemically modified siRNAs [ J ]. Mini Rev Med Chem,2010, 10 ( 7 ) :578-595. 被引量:1
  • 10Sadaka A, Giuliari D. Proliferative vitreoretinopathy: current and emerging treatments [J ]. Clin Ophthalmol, 2012,6 : 1325- 1333. 被引量:1

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部